Abstract:Shiyang Wang, 1, 2 Tianlong Wang, 1 Li Wang, 1 Liansheng Zhong, 3 Kai Li 2 1 Department of Geriatric Surgery, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 2 Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 3 Department of Bioinformatics, College of Life Science, China Medical University, Shenyang 110001, People's Republic of China Correspondence: Kai Li Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China Tel +86-13998245233 Email cmu_likai@163.com Background: RING finger protein 126 (RNF126), as a novel E3 ubiquitin ligase, plays an oncogenic role in several solid cancers. But its potential role in colorectal cancer (CRC) that harbored 50% mutant p53, to our knowledge, is rarely reported. Materials and Methods: We investigated the clinical significance and relationship of RNF126 and p53 in CRC tissues and cells. Meanwhile, WB, qRT-PCR, co-IP, MTT, and transwell were used to investigate the function and molecular mechanism of RNF126 in regulating malignant biology in vitro. Results: RNF126 was overexpressed in human CRC specimens, which was tightly associated with tumor size ( P =0.021), T stage ( P =0.030), lymph node metastasis ( P =0.006), TNM stage ( P =0.001), and the poor survival ( P =0.003) of CRC patients. RNF126 had no association with p53 mutation in CRC specimens, and in p53 mutant Colo-205 and SW620 cells. However, in p53 wildtype HCT116 and HCT-8 cells, RNF126 silencing upregulated p53 and p21 but inhibited Rb phosphorylation at Serine 780 (pRb), which was inhibited by p53siRNA. Conversely, RNF126 overexpression downregulated p53 and p21 but promoted pRb expression, which was reversed by a classic proteasome inhibitor, MG132. However, the mRNA levels of above target genes were unchanged, implying a ubiquitination dependent post-translational modification involving in above regulation. Meanwhile, RNF126 was co-immunoprecipitated with p53 and p21 to form a triple complex. RNF126 silencing and overexpression inhibited and promoted p53 ubiquitination and degradation in vitro, respectively. In addition, p53siRNA reversed RNF126 silencing-inhibited cell proliferation, drug resistance, and cell mobility in HCT116 cells. Conversely, MG132 inhibited RNF126 overexpression-promoted above cell biology in HCT-8 cells. Conclusion: Overexpression of RNF126 was remarkably associated with multiple advanced clinical characters of CRC patients independent of mutant p53. RNF126 promotes cell proliferation, mobility, and drug resistance in CRC via enhancing p53 ubiquitination and degradation. Keywords: RING finger protein 126, p53, ubiquitination, colorectal cancer

Knockdown Of Rck/P54 Expression By Rnai Inhibits Proliferation Of Human Colorectal Cancer Cells In Vitro And In Vivo

Up-regulated NRIP2 in Colorectal Cancer Initiating Cells Modulates the Wnt Pathway by Targeting RORβ.

Effects of Heterogously- Expressed RON Receptor Tyrosine Kinase on Motile/invasive Ability of Human Colorectal Cancer Cell Line RKO

Knockdown of Rhotekin 2 Expression Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells

Knockdown of reticulon 4C by lentivirus inhibits human colorectal cancer cell growth.

Knockdown of the Novel Proteasome Subunit Adrm1 Located on the 20q13 Amplicon Inhibits Colorectal Cancer Cell Migration, Survival and Tumorigenicity.

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation

KNOCKDOWN OF CASEIN KINASE le INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/beta-CATENIN SIGNALING

Ribosomal Protein RPS15A Augments Proliferation of Colorectal Cancer RKO Cells Via Regulation of BIRC3, P38 MAPK and Chk1.

RNF114 facilitates the proliferation, stemness, and metastasis of colorectal cancer

KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/β-CATENIN SIGNALING.

Long Noncoding RNA RP11-278A23.1, a Potential Modulator of p53 Tumor Suppression, Contributes to Colorectal Cancer Progression

Wnt Signaling Modulator DKK4 Inhibits Colorectal Cancer Metastasis Through an AKT/Wnt/β-catenin Negative Feedback Pathway.

Knockdown of Linc-Pou3f3 Suppresses the Proliferation, Apoptosis, and Migration Resistance of Colorectal Cancer

RRS1 Silencing Suppresses Colorectal Cancer Cell Proliferation and Tumorigenesis by Inhibiting G2/M Progression and Angiogenesis

Circppp2r4 Promotes Colorectal Cancer Progression and Reduces ROS Production Through the Mir‐646/foxk1 Axis

Oncogenic Retinoic Acid Receptor Γ Knockdown Reverses Multi-Drug Resistance of Human Colorectal Cancer Via Wnt/β-catenin Pathway

ROR1-AS1 Promotes Tumorigenesis of Colorectal Cancer Via Targeting Wnt/β-catenin.

The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB

Up-regulation of LINC00467 Promotes the Tumourigenesis in Colorectal Cancer.

Downregulation of ZNF280A inhibits proliferation and tumorigenicity of colorectal cancer cells by promoting the ubiquitination and degradation of RPS14